Emiko M•••

About

On the record

A brief assessment of productivity: • Principal Investigator on 20 grants to date (2 active and 1 pending). • 120 original articles, 30 review articles, 11 as first author, 35 as last author; corresponding author on 30 papers to date. • 20 oral and 25 poster presentations at national/international meetings from 2006 to date. • Invited speakers in 20 international and 33 domestic meetings from 2006 to date. The quality of the contributions: • Actively investigating functional modulation of colonic epithelial cells in murine models of colitis to complete our understanding of the pathogenesis of IBD. • One of the internationally recognized investigators in the fields of epithelial biology, animal models of IBD, as well as colitis-associated carcinogenesis. • Significant contribution to the investigators at Harvard through my outstanding IHC analyses and disease evaluation skills, which are indispensable in IBD research. • Reliable and opinionated grant/manuscript reviewer on Immunological/Gastroenterological topics is my unique combination of expertise. • A strong track record of mentoring post-doctoral research fellows in my laboratory who bring their own research fellowship funds. The teaching activities: • >0 years as a supervisor/tutor for research fellows and students. • Ad hoc grant reviewer for NIH including NIGMS/MBRS, TME, and GMPB study sections. • Ad hoc grant reviewer for national/international foundations in 7 countries from 2010 to date. • Ad hoc reviewer for 57 leading journals including Gastroenterology, Gut, J Exp Med, and JCI since 2001 to date. • Editorial Board Member for 11 leading journals including PLoS One. • Invited speaker/lecturer of national/international meetings and symposiums. Source of funds: NIH R01 DK091247 (PI)$217K x 5 yr. IL-22 pathway in IBD NIH R01 AI081807 (PI)$202K x 4 yr. Inducible regulatory B cells iBreg NIH R01 DK080070 (PI)$250K x 5 yr. Role of mammalian chitinases in IBD 3 JSPS grants supported by Japanese government